| Schedule of Cash and Cash Equivalents |
Cash,
cash equivalents, and restricted stock consisted of the following:
Schedule
of Cash and Cash Equivalents
| |
|
September 30,
2020 |
|
|
December 31, 2019 |
|
| Cash |
|
$ |
3,962,572 |
|
|
$ |
884,115 |
|
| Money market fund |
|
|
77,908,079 |
|
|
|
30,864,571 |
|
| Cash and cash equivalents |
|
|
81,870,651 |
|
|
$ |
31,748,686 |
|
| |
|
|
|
|
|
|
|
|
| Restricted cash, current |
|
|
350,000 |
|
|
|
— |
|
| Restricted cash, noncurrent |
|
|
669,900 |
|
|
|
— |
|
| Restricted cash |
|
|
1,019,900 |
|
|
|
— |
|
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
|
$ |
82,890,551 |
|
|
$ |
31,748,686 |
|
|
| Schedule of Computation of Net Loss Per Common Share |
Net
loss per share was computed as follows:
Schedule of Computation of Net Loss Per Common Share
| |
|
Three
Months Ended September
30
|
|
|
Nine
Months Ended September
30
|
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(34,895,349 |
) |
|
$ |
(20,790,801 |
) |
|
$ |
(102,657,472 |
) |
|
$ |
(44,872,957 |
) |
| Weighted average
number of common shares-diluted* |
|
|
81,879,119 |
|
|
|
64,660,017 |
|
|
|
75,037,418 |
|
|
|
63,638,447 |
|
|
Net
loss per share of common stock-basic and diluted*
|
|
$ |
(0.43 |
) |
|
$ |
(0.32 |
) |
|
$ |
(1.37 |
) |
|
$ |
(0.71 |
) |
| * |
* Warrants
and options that have not been exercised have been excluded from the diluted calculation as all periods presented have a net
loss and the impact of these securities would be anti-dilutive |
|